CSIMarket
 
Asensus Surgical Inc   (NYSE: ASXC)
Other Ticker:  
 
 
Price: $0.3479 $0.00 0.636%
Day's High: $0.3495 Week Perf: 21.86 %
Day's Low: $ 0.35 30 Day Perf: 2.66 %
Volume (M): 4,001 52 Wk High: $ 0.38
Volume (M$): $ 1,392 52 Wk Avg: $0.29
Open: $0.35 52 Wk Low: $0.17



 Market Capitalization (Millions $) 95
 Shares Outstanding (Millions) 272
 Employees -
 Revenues (TTM) (Millions $) 4
 Net Income (TTM) (Millions $) -87
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 1

Asensus Surgical Inc
Asensus Surgical Inc is a medical technology company that specializes in the development of surgical robotic systems. Their flagship product, the Senhance Surgical System, is designed to assist surgeons in performing minimally invasive surgery with improved precision and control. The system integrates robotic arms with instruments that can be controlled by the surgeon from a console. This allows for enhanced dexterity and flexibility during procedures. Asensus Surgical Inc aims to improve patient outcomes and reduce healthcare costs through their innovative robotic technology.


   Company Address: 1 TW Alexander Drive, Suite 160 Durham 27703 NC
   Company Phone Number: 765-8400   Stock Exchange / Ticker: NYSE ASXC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BSX   -1.93%    
EW   -1.93%    
ISRG   -0.53%    
MDT   -2.05%    
SYK   -2.55%    
ZBH   -1.13%    
• View Complete Report
   



Merger and Acquisition

KARL STORZ Acquires Asensus Surgical Inc. to Establish Cutting-Edge Surgical Robotics Hub

Published Thu, Aug 22 2024 2:11 PM UTC



Breaking News
KARL STORZ Acquires US-Headquartered Asensus Surgical Inc. to Create a Surgical Robotics Hub and Drive Performance-Guided Surgery
In a significant move set to revolutionize the field of surgical robotics, KARL STORZ, a renowned leader in the medical technology sector, has announced its acquisition of US-based Asensus Surgical Inc. (NYSE: A...

Stock Market Announcement

Glass Lewis Endorses Asensus Surgical's Merger Proposal, Boosting Confidence in Company Shares

Published Mon, Jul 29 2024 10:46 AM UTC



In a recent press release, Asensus Surgical, Inc. (NYSE American: ASXC), a renowned global leader in innovative digital solutions for the operating room, disclosed that Glass, Lewis & Co. (Glass Lewis), a leading independent proxy advisory firm, has urged Asensus Surgical stockholders to vote in favor of all proposals related to the impending merger with KARL STORZ...

Contract

Revolutionizing Pediatric Surgery The Senhance System Takes Center Stage at Denvers Rocky Mountain Hospital for Chil...

Published Wed, Jul 24 2024 10:51 AM UTC

Asensus Surgical is proud to announce a groundbreaking development in the field of pediatric surgery - the initiation of the Senhance Surgery Program at The Rocky Mountain Hospital for Children in Denver, Colorado. This remarkable milestone marks the first-ever placement of the Senhance System at a dedicated pediatric hospital in the United States, bringing a new era of inno...

Product Service News

Asensus Surgical Receives FDA Clearance for Senhance Surgical System in Urology, Achieves Impressive Revenue Growth...

Published Tue, Jul 23 2024 10:50 AM UTC

Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology, Showing Promising Growth in Revenue RESEARCH TRIANGLE PARK, N.C. - Asensus Surgical, Inc. (NYSE American: ASXC), a global leader in innovative digital solutions for the operating room, has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an expanded ...

Contract

Unleashing Precision and Connectivity Asensus Surgical Transforms Surgical Landscape in Japan

Published Mon, Jun 24 2024 10:55 AM UTC

In a significant stride towards revolutionizing surgical procedures, Asensus Surgical, Inc. has announced a remarkable collaboration with the prestigious St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan. This ground-breaking agreement involves the deployment of Asensus Surgical's cutting-edge Senhance Surgical System, aimed at transforming the...







Asensus Surgical Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com